Log on / register
Feedback | Support | My details
Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS).
Wehmeier PM, Schacht A, Lehmann M, Dittmann RW, Silva SG, March JS
Child Adolesc Psychiatry Ment Health 2008, 2:11
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned.
Shapiro M, Silva SG, Compton S, Chrisman A, Deveaugh-Geiss J, Breland-Noble A, Kondo D, Kirchner J, March JS
Child Adolesc Psychiatry Ment Health 2009, 3:12
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.